| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08c6e327309f4daa7f6694f7b5d6c8bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-99004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-99001 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-99004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y204-99001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8125 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31655556a2572d64ccb5da6664bb84cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f7ee8b2efc7d3582d503867a226b19d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61e0706fd837033aa0e290358b64b86a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55e5c16dc57de5cbfcf7bed69d7b6b75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2698ddb54c92d2bdaf880e15c97b5075 |
| publicationDate |
2022-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2916409-T3 |
| titleOfInvention |
Recombinant glycoproteins with reduced antennal fucosylation |
| abstract |
A method for reducing antennal fucosylation of complex N-glycans in a glycoprotein that is recombinantly expressed in a human primary amniocyte cell line, wherein said cell line comprises at least one nucleic acid encoding gene products of adenoviral regions E1 and pIX, and wherein said cell line is genetically modified to overexpress β-galactoside α-2,6-sialyltransferase 1 (ST6Gal1) and/or β-galactoside α-2,3-sialyltransferase 4 (ST3Gal4) compared to the sialyltransferase expression level before genetic modification. |
| priorityDate |
2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |